Gender (%) | Male | 91 (27.2) |
---|---|---|
Female | 243 (72.8) | |
Type of vaccine (%) | Astrazeneca | 43 (12.9) |
Sinopharm | 54 (16.2) | |
Sputnik | 208 (62.3) | |
Baharat | 23 (6.9) | |
Others | 6 (1.8) | |
COVID-19 severity (%) | Hospitalization | 108 (32.3) |
ICU admission | 17 (5.1) | |
Quarantine at home | 209 (62.6) | |
Concomitant symptoms (%) | Joint pain | 59 (17.7) |
Chilling | 13 (3.9) | |
Muscular pain | 72 (21.6) | |
Runny nose | 23 (6.9) | |
Sleep problem | 6 (1.8) | |
Dizziness | 8 (2.4) | |
Neural symptoms | 20 (6.0) | |
PCR positivity after vaccination (%) | 2 (0.6) | |
Analgesic use after vaccination (%) | 28 (8.4) |